Member Exclusive

Drug derived from malaria parasite could be utilized in bladder cancer

Researchers at the University of British Columbia (Vancouver, BC, Canada) have demonstrated that a drug created from a malaria protein, stopped tumour growth of chemotherapy-resistant bladder cancer, offering hope for cancer patients not responding to standard treatments.

Go to the profile of Peter Brown
May 10, 2017

Please sign in or register for FREE

Register to MedChemNet

MedChemNet is a communal space where industry and academic professionals can come together to discuss the latest research and developments, share thoughts and opinions, and build valuable international relationships.


No comments yet.